Beijing Konruns Pharmaceutical Co (SHSE:603590) Total Liabilities : ¥363.5 Mil (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Beijing Konruns Pharmaceutical Co Total Liabilities?

Beijing Konruns Pharmaceutical Co's Total Liabilities for the quarter that ended in Sep. 2023 was ¥363.5 Mil.

Beijing Konruns Pharmaceutical Co's quarterly Total Liabilities increased from Mar. 2023 (¥296.58 Mil) to Jun. 2023 (¥359.16 Mil) and increased from Jun. 2023 (¥359.16 Mil) to Sep. 2023 (¥363.47 Mil).

Beijing Konruns Pharmaceutical Co's annual Total Liabilities declined from Dec. 2020 (¥701.73 Mil) to Dec. 2021 (¥240.74 Mil) and declined from Dec. 2021 (¥240.74 Mil) to Dec. 2022 (¥234.68 Mil).

Beijing Konruns Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Beijing Konruns Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Konruns Pharmaceutical Co Total Liabilities Chart

Beijing Konruns Pharmaceutical Co Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

439.48

445.85

701.73

240.74

234.68

Beijing Konruns Pharmaceutical Co Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Total Liabilities	Get a 7-Day Free Trial															204.31	234.68	296.58	359.16	363.47

Beijing Konruns Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Beijing Konruns Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	172.363	+	(3.708	+	58.604
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	234.7

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	3424.801	-	3190.125
	=	234.7

Beijing Konruns Pharmaceutical Co's Total Liabilities for the quarter that ended in Sep. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	247.592	+	(48.898	+	66.982
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	363.5

Total Liabilities	=	Total Assets (Q: Sep. 2023 )	-	Total Equity (Q: Sep. 2023 )
	=	3776.504	-	3413.032
	=	363.5

Beijing Konruns Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Beijing Konruns Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Konruns Pharmaceutical Co (SHSE:603590) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Konruns Pharmaceutical Co Ltd (SHSE:603590) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11 Xingsheng South Road, Economic Development Zone, Miyun District, Beijing, CHN

Website

http://www.konruns.cn

Beijing Konruns Pharmaceutical Co Ltd is a Chinese pharmaceutical company. It is engaged in the research and development of innovative drugs, and is oriented to clinical needs.

Beijing Konruns Pharmaceutical Co (SHSE:603590) Headlines

No Headlines